BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 35291601)

  • 1. Lectin-Like OLR1 3'UTR Rs1050286 Gene Polymorphism and Plasma Oxidized-LDL in Coronary Artery Disease and Their Relation to Cardiovascular Risk and Outcomes.
    Mohammed HSE; Kamal MM; ElBadre HM; Hosni A; Elfadl AA; Mostafa MA; El-Mahdy RI
    Rep Biochem Mol Biol; 2022 Jan; 10(4):537-553. PubMed ID: 35291601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The human rs1050286 polymorphism alters LOX-1 expression through modifying miR-24 binding.
    Morini E; Rizzacasa B; Pucci S; Polidoro C; Ferrè F; Caporossi D; Helmer Citterich M; Novelli G; Amati F
    J Cell Mol Med; 2016 Jan; 20(1):181-7. PubMed ID: 26542080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The 3'-UTR C>T polymorphism of the oxidized LDL-receptor 1 (OLR1) gene does not associate with coronary artery disease in Italian CAD patients or with the severity of coronary disease.
    Sentinelli F; Filippi E; Fallarino M; Romeo S; Fanelli M; Buzzetti R; Berni A; Baroni MG
    Nutr Metab Cardiovasc Dis; 2006 Jul; 16(5):345-52. PubMed ID: 16829343
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Jamatia E; Lali P; Koner BC; Dhanwal DK; Masroor M; Krishnamurthy K; Singh A
    Indian J Endocrinol Metab; 2018; 22(4):530-534. PubMed ID: 30148103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of lectin-like oxidized low density lipoprotein receptor 1 (
    Wang ZT; Zhong XL; Tan MS; Wang HF; Tan CC; Zhang W; Zheng ZJ; Kong LL; Tan L; Sun L
    Ann Transl Med; 2018 May; 6(10):172. PubMed ID: 29951494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of OLR1 gene polymorphisms with the risk of coronary artery disease: A systematic review and meta-analysis.
    Salehipour P; Rezagholizadeh F; Mahdiannasser M; Kazerani R; Modarressi MH
    Heart Lung; 2021; 50(2):334-343. PubMed ID: 33524863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Failure to replicate an association of SNPs in the oxidized LDL receptor gene (OLR1) with CAD.
    Knowles JW; Assimes TL; Boerwinkle E; Fortmann SP; Go A; Grove ML; Hlatky M; Iribarren C; Li J; Myers R; Risch N; Sidney S; Southwick A; Volcik KA; Quertermous T
    BMC Med Genet; 2008 Apr; 9():23. PubMed ID: 18384690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical significance of antibody against oxidized low density lipoprotein in patients with atherosclerotic coronary artery disease.
    Inoue T; Uchida T; Kamishirado H; Takayanagi K; Hayashi T; Morooka S
    J Am Coll Cardiol; 2001 Mar; 37(3):775-9. PubMed ID: 11693751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Are IVS4 SNPs of OLR1 gene associated with coronary artery disease: Is there a linkage between IVS4 SNPs?
    Kurnaz-Gomleksiz O; Kucukhuseyin O; Ozkok E; Bugra Z; Ozturk O; Yilmaz-Aydogan H
    Adv Clin Exp Med; 2018 Mar; 27(3):321-326. PubMed ID: 29558038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of six single nucleotide polymorphisms, risk factors in coronary disease, in OLR1 alternative splicing.
    Tejedor JR; Tilgner H; Iannone C; Guigó R; Valcárcel J
    RNA; 2015 Jun; 21(6):1187-202. PubMed ID: 25904137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IVS4-14 A/G and IVS4-73 C/T polymorphisms in OLR1 gene in patients with ischemic cerebrovascular diseases.
    Vietri MT; Molinari AM; Boggia M; Parisi M; Cioffi M
    Genet Test Mol Biomarkers; 2010 Feb; 14(1):9-11. PubMed ID: 19929426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The oxidation ratio of LDL: a predictor for coronary artery disease.
    Huang H; Mai W; Liu D; Hao Y; Tao J; Dong Y
    Dis Markers; 2008; 24(6):341-9. PubMed ID: 18688083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. On the association of the oxidised LDL receptor 1 (OLR1) gene in patients with acute myocardial infarction or coronary artery disease.
    Trabetti E; Biscuola M; Cavallari U; Malerba G; Girelli D; Olivieri O; Martinelli N; Corrocher R; Pignatti PF
    Eur J Hum Genet; 2006 Jan; 14(1):127-30. PubMed ID: 16251892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathophysiological role of oxidized low-density lipoprotein in plaque instability in coronary artery diseases.
    Ehara S; Ueda M; Naruko T; Haze K; Matsuo T; Ogami M; Ikura Y; Itabe H; Komatsu R; Yoshiyama M; Takeuchi K; Yoshikawa J
    J Diabetes Complications; 2002; 16(1):60-4. PubMed ID: 11872369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic variation in lectin-like oxidized low-density lipoprotein receptor 1 (LOX1) gene and the risk of coronary artery disease.
    Chen Q; Reis SE; Kammerer C; Craig WY; LaPierre SE; Zimmer EL; McNamara DM; Pauly DF; Sharaf B; Holubkov R; Bairey Merz CN; Sopko G; Bontempo F; Kamboh MI
    Circulation; 2003 Jul; 107(25):3146-51. PubMed ID: 12810610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma oxidized low-density lipoprotein is an independent risk factor in young patients with coronary artery disease.
    Huang Y; Hu Y; Mai W; Cai X; Song Y; Wu Y; Dong Y; Huang H; He Z; Li W; Yang Y; Rao S
    Dis Markers; 2011; 31(5):295-301. PubMed ID: 22048271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum high-density lipoprotein-cholesterol levels modify the association between plasma levels of oxidatively modified low-density lipoprotein and coronary artery disease in men.
    Zhang B; Bai H; Liu R; Kumagai K; Itabe H; Takano T; Saku K
    Metabolism; 2004 Apr; 53(4):423-9. PubMed ID: 15045686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxidized Low Density Lipoprotein and High Sensitive C-Reactive Protein in Non-Diabetic, Pre-Diabetic and Diabetic Patients in the Acute Phase of the First Myocardial Infarction Treated by Primary Percutaneous Coronary Intervention.
    Trifunović D; Stanković S; Marinković J; Banović M; Đukanović N; Vasović O; Vujisić-Tešić B; Petrović M; Stepanović J; Đorđević-Dikić A; Beleslin B; Nedeljković I; Tešić M; Ostojić M
    J Med Biochem; 2015 Apr; 34(2):160-169. PubMed ID: 28356828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lectin-like oxidized-LDL receptor-1 (LOX-1) polymorphisms influence cardiovascular events rate during statin treatment.
    Puccetti L; Pasqui AL; Bruni F; Pastorelli M; Ciani F; Palazzuoli A; Pontani A; Ghezzi A; Auteri A
    Int J Cardiol; 2007 Jun; 119(1):41-7. PubMed ID: 17050011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma oxidized high-density lipoprotein and glycated apolipoprotein A-I concentrations in ST-segment elevation myocardial infarction patients with stress hyperglycaemia or high thrombus burden.
    Li BQ; Zhong YC; Wang X
    Ups J Med Sci; 2018 Sep; 123(3):158-166. PubMed ID: 30259778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.